Dr. Mark A. Munger shares his team's research on the concomitant use of NSAIDs plus misoprostol and the associated reduced risk of NSAID-induced cardiovascular, cerebrovascular, and renal adverse events. Full text manuscript available at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2708.